|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expense | |||||
| Change in fair value of contingent consideration | |||||
| Operating income | |||||
| Other income, net | |||||
| Impairment of equity investment | |||||
| Interest expense, net | |||||
| Loss on extinguishment of debt | |||||
| Income before provision for income taxes | |||||
| Income tax provision | |||||
| Net income | |||||
| Comprehensive income | |||||
| Net income per share: | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
